Dr. Sunita Shukla is currently a scientific reviewer in FDA’s Office of In Vitro Diagnostics and Radiological Health (OIR), Division of Chemistry and Toxicology Devices (DCTD). Dr. Shukla is responsible for both premarket and postmarket review activities in her Division. Prior to joining FDA in 2011, she was a postdoctoral fellow at the National Center for Advancing Translational Sciences (NCATS) at NIH and her research focused on quantitative high throughput screening and in vitro toxicity testing using a variety of biochemical and cell-based assays in 1,536 well format. Dr. Shukla received her Ph.D in Human Genetics from the University of Chicago and received her Master of Public Health degree and B.A. in English from Saint Louis University.